Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

First 20 Last

Share
Profile

Follow
Wasabi193

1,584 Posts.

396

27/04/23

17:45

Post #: 67486796
Share

Originally posted by thevinnys: ↑

Welcome Wasabi

2. What environment would be needed to raise "investor expectations" for the future of Incannex and a possible increase in its' Market Cap Value?

A. IHL-42X - 2023-24

>> IHL-42X - Opening Clinical Trials for Phase 2/3 in the U.S.A. Sleep Clinics will raise the Profile of IHL-42X as a possible alternative medication for OSA
>> IHL-42X - Preliminary Trial Results from USA Trials from Phase 2 (with success), then progressing immediately into Phase 3 will also raise the profile.

B. PSI-GAD 2023-24

>> Completion of the Phase 2 Monash Trial by the end of the year and the possible release of the results early next year will raise the profile of PSI as a possible therapy for GAD.

And with what appears to be mostly bi-partisan support for Psychedelics Therapies in US politics that bodes well too for a lead into the opening of an IND with the FDA around the same time as MAPS PBC receiving approval from the FDA for its MDMA Treatment for PTSD, with approx 1.9M Veterans eligible for treatment. As I have said previously there is commentary stating that any FDA approval for any indications using any Psychedelics will be worth Billions for that company and lift the profile of the whole Pyschedelics Industry.

C. Psychedelics Clinics 2023-4

>> Peter Widdows's reputation precedes him! Read up on his experience.

As I have posted today, plans have been made to use clinics as Real World Research Labs, and refer to commentary from@Flectionaltoo.
As@rhino78I think mentioned recently, our clinics will be available to treat other patients for other indications also.
Some Clinics in the USA such as those operated by Numinous (https://numinus.com/) have had some positive feedback for the services they provide to the Psychedelics Industry.
Our Psychennex Clinics will lift the PUBLIC profile of our PSI-GAD program, subject to the success of the trial and the opening of the 1st clinic by the end of the year.

AB & C IMO are the real catalysts for an increase in IHL's Profile for New Investors' Expectations, this is not a short-term journey as@kingkevconsistently reminds all investors.
https://hotcopper.com.au/threads/ihl-incannex-holders-research.6278647/page-730?post_id=67298653

Good luck @Wasabi193

Expand

Very much appreciated, great insights as always and I’ll use this info as the foundation to get back up to speed.

IHL Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 2 more messages in this thread...

First 20 Last

Add IHL (ASX) to my watchlist

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News